233 related articles for article (PubMed ID: 32087357)
21. The BLISTER Score: A Novel, Externally Validated Tool for Predicting Cardiac Implantable Electronic Device Infections, and Its Cost-Utility Implications for Antimicrobial Envelope Use.
Maclean E; Mahtani K; Honarbakhsh S; Butcher C; Ahluwalia N; Dennis ASC; Creta A; Finlay M; Elliott M; Mehta V; Wijesuriya N; Shaikh O; Zaw Y; Ogbedeh C; Gautam V; Lambiase PD; Schilling RJ; Earley MJ; Moore P; Muthumala A; Sporton SCE; Hunter RJ; Rinaldi CA; Behar J; Martin C; Monkhouse C; Chow A
Circ Arrhythm Electrophysiol; 2024 Mar; 17(3):e012446. PubMed ID: 38258308
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of antibiotic prophylaxis before the implantation of pacemakers and cardioverter-defibrillators: results of a large, prospective, randomized, double-blinded, placebo-controlled trial.
de Oliveira JC; Martinelli M; Nishioka SA; Varejão T; Uipe D; Pedrosa AA; Costa R; D'Avila A; Danik SB
Circ Arrhythm Electrophysiol; 2009 Feb; 2(1):29-34. PubMed ID: 19808441
[TBL] [Abstract][Full Text] [Related]
23. Antibiotic prophylaxis based on individual infective risk stratification in cardiac implantable electronic device: the PRACTICE study.
Malagù M; Vitali F; Brieda A; Cimaglia P; De Raffele M; Tazzari E; Musolino C; Balla C; Serenelli M; Cultrera R; Rapezzi C; Bertini M
Europace; 2022 Mar; 24(3):413-420. PubMed ID: 34487163
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of a Bio-Absorbable Antibacterial Envelope to Prevent Cardiac Implantable Electronic Device Infections in High-Risk Subjects.
Kolek MJ; Patel NJ; Clair WK; Whalen SP; Rottman JN; Kanagasundram A; Shen ST; Saavedra PJ; Estrada JC; Abraham RL; Ellis CR
J Cardiovasc Electrophysiol; 2015 Oct; 26(10):1111-6. PubMed ID: 26222980
[TBL] [Abstract][Full Text] [Related]
25. Preoperative skin antiseptics for prevention of cardiac implantable electronic device infections: a historical-controlled interventional trial comparing aqueous against alcoholic povidone-iodine solutions.
Da Costa A; Tulane C; Dauphinot V; Terreaux J; Romeyer-Bouchard C; Gate-Martinet A; Levallois M; Isaaz K
Europace; 2015 Jul; 17(7):1092-8. PubMed ID: 25917024
[TBL] [Abstract][Full Text] [Related]
26. The role of an antibiotic envelope in the prevention of major cardiac implantable electronic device infections: A systematic review and meta-analysis.
Asbeutah AAA; Salem MH; Asbeutah SA; Abu-Assi MA
Medicine (Baltimore); 2020 Jun; 99(26):e20834. PubMed ID: 32590773
[TBL] [Abstract][Full Text] [Related]
27. Antibiotic eluting envelopes: evidence, technology, and defining high-risk populations.
Callahan TD; Tarakji KG; Wilkoff BL
Europace; 2021 Jun; 23(23 Suppl 4):iv28-iv32. PubMed ID: 34160597
[TBL] [Abstract][Full Text] [Related]
28. Risk factors for cardiac implantable electronic device infection: a systematic review and meta-analysis.
Polyzos KA; Konstantelias AA; Falagas ME
Europace; 2015 May; 17(5):767-77. PubMed ID: 25926473
[TBL] [Abstract][Full Text] [Related]
29. Use of antibiotic envelopes to prevent cardiac implantable electronic device infections: A meta-analysis.
Koerber SM; Turagam MK; Winterfield J; Gautam S; Gold MR
J Cardiovasc Electrophysiol; 2018 Apr; 29(4):609-615. PubMed ID: 29364546
[TBL] [Abstract][Full Text] [Related]
30. Economic evaluation of an absorbable antibiotic envelope for prevention of cardiac implantable electronic device infection.
Rennert-May E; Raj SR; Leal J; Exner DV; Manns BJ; Chew DS
Europace; 2021 May; 23(5):767-774. PubMed ID: 33554239
[TBL] [Abstract][Full Text] [Related]
31. The never-ending story of CIED infection prevention: Shall we WRAP-IT and go?
Biffi M
J Cardiovasc Electrophysiol; 2019 Aug; 30(8):1191-1196. PubMed ID: 31172637
[TBL] [Abstract][Full Text] [Related]
32. Trends of Cardiovascular Implantable Electronic Device Infection in 3 Decades: A Population-Based Study.
Dai M; Cai C; Vaibhav V; Sohail MR; Hayes DL; Hodge DO; Tian Y; Asirvatham R; Cochuyt JJ; Huang C; Friedman PA; Cha YM
JACC Clin Electrophysiol; 2019 Sep; 5(9):1071-1080. PubMed ID: 31537337
[TBL] [Abstract][Full Text] [Related]
33. The impact of changing antiseptic skin preparation agent used for cardiac implantable electronic device (CIED) procedures on the risk of infection.
Qintar M; Zardkoohi O; Hammadah M; Hsu A; Wazni O; Wilkoff BL; Tarakji KG
Pacing Clin Electrophysiol; 2015 Feb; 38(2):240-6. PubMed ID: 25224666
[TBL] [Abstract][Full Text] [Related]
34. Use of an antibacterial envelope is associated with reduced cardiac implantable electronic device infections in high-risk patients.
Kolek MJ; Dresen WF; Wells QS; Ellis CR
Pacing Clin Electrophysiol; 2013 Mar; 36(3):354-61. PubMed ID: 23252988
[TBL] [Abstract][Full Text] [Related]
35. Antibiotic Prophylaxis and Treatment in Early Cardiac Implantable Electronic Devices Infection.
Alshoubaki O; Al Darabaa Z; Odat O; Qubbaj A; Alhyari R; Alshare S; Ghanma I
Med Arch; 2021 Feb; 75(1):56-60. PubMed ID: 34012201
[TBL] [Abstract][Full Text] [Related]
36. Risk profiles and outcomes of patients receiving antibacterial cardiovascular implantable electronic device envelopes: A retrospective analysis.
Woodard DA; Kim G; Nilsson KR
World J Cardiol; 2022 Mar; 14(3):177-186. PubMed ID: 35432770
[TBL] [Abstract][Full Text] [Related]
37. Health and Economic Outcomes Associated with Use of an Antimicrobial Envelope as a Standard of Care for Cardiac Implantable Electronic Device Implantation.
Shariff N; Eby E; Adelstein E; Jain S; Shalaby A; Saba S; Wang NC; Schwartzman D
J Cardiovasc Electrophysiol; 2015 Jul; 26(7):783-9. PubMed ID: 25845917
[TBL] [Abstract][Full Text] [Related]
38. Real-life outcome of implantable cardioverter-defibrillator and cardiac resynchronization defibrillator replacement/upgrade in a contemporary population: observations from the multicentre DECODE registry.
Biffi M; Ammendola E; Menardi E; Parisi Q; Narducci ML; De Filippo P; Manzo M; Stabile G; Potenza DR; Zanon F; Quartieri F; Rillo M; Saporito D; Zacà V; Berisso MZ; Bertini M; Tumietto F; Malacrida M; Diemberger I
Europace; 2019 Oct; 21(10):1527-1536. PubMed ID: 31209482
[TBL] [Abstract][Full Text] [Related]
39. Infection control in implantation of cardiac implantable electronic devices: current evidence, controversial points, and unresolved issues.
Korantzopoulos P; Sideris S; Dilaveris P; Gatzoulis K; Goudevenos JA
Europace; 2016 Apr; 18(4):473-8. PubMed ID: 26516219
[TBL] [Abstract][Full Text] [Related]
40. Low lateral thoracic site for cardiac implantable electronic device implantation: A viable alternative in patients with limited access options after infected device extraction.
Liang JJ; Schaller RD; Modi DS; Enriquez A; Supple GE; Cooper JM
Heart Rhythm; 2017 Oct; 14(10):1506-1514. PubMed ID: 28603001
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
